Patent ID: 7871994

Claim:
A method for hormone replacement therapy in a female in need thereof having a (B) postmenopause period and a (A) preceding period in which said female is in need of HRT, and which comprises at least one ingestion period during which at least one hormone component comprising at least one estrogen (E) and/or at least one gestagen (G) compound is administered, comprising in the established (B) postmenopause period of said patient, every day permanently and continuously administering a daily unit with at least one hormonal component comprising at least one estrogen (E) and/or at least one gestagen (G) component, and in at least one ingestion period during said (A) preceding period in which said female is in need of HRT, providing an (y) ingestion pause (P), and administering during said pause no daily units, placebos or daily units with a much lower estrogen and/or gestagen content than the content thereof used during the permanent administration of hormone daily units in the established (B) postmenopause period and during the (x) ingestion phase(s) of said ingestion period wherein said (A) preceding period comprises at least two ingestion periods having (x) ingestion phases which are successively extended with respect to each other.